Old Web
English
Sign In
Acemap
>
authorDetail
>
Margit Janat-Amsbury
Margit Janat-Amsbury
Amgen
Cancer research
Medicine
CD3
Glutamate carboxypeptidase II
infiltration
2
Papers
1
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Safety and efficacy of AMG 160, a half-life extended BiTE immune therapy targeting prostate-specific membrane antigen (PSMA), and other therapies for metastatic castration-resistant prostate cancer (mCRPC).
2021
Journal of Clinical Oncology
Sumit K. Subudhi
Bilal A. Siddiqui
Joseph Maly
Lakshminarayanan Nandagopal
Elaine Tat Lam
Young E. Whang
Mukul Minocha
Vinita Gupta
Xianne Penny
Freda Cooner
Camila Jhones
Andrew Paluch
Mark Salvati
Margit Janat-Amsbury
Tobias Eggert
Hosein Kouros-Mehr
Anthony M. Joshua
Rahul Aggarwal
Johann S. de Bono
Show All
Source
Cite
Save
Citations (1)
P11.02 Targeting the Tumor Neovasculature in Lung Cancer: A Phase I Study of AMG 160 in Subjects With Non-Small Cell Lung Cancer
2021
Journal of Thoracic Oncology
George R. Blumenschein
T. Eggert
Aditya Shetty
Margit Janat-Amsbury
Hosein Kouros-Mehr
A.S. Bhatia
V. Gupta
S. Tiso
Mark Salvati
Michael Boyer
Show All
Source
Cite
Save
Citations (0)
1